ANNUAL CONFERENCES

Connect with Academic Experts, Community Healthcare Providers and Industry Leaders

Today’s oncology and hematology conferences connect healthcare providers (HCPs) such as yourself to the best researchers and thought leaders in the industry on local, regional, and global scales. Offering virtual, in-person, or hybrid experiences, these conferences are flexible and adaptable to your needs and exist to deliver the latest data and medical research in engaging and informative ways. Collected here are the current and upcoming events we think you may be interested in, including links to registration or more information.

International Workshop on Chronic Lymphocytic Leukemia

September 6-9, 2023 - Live and Virtual

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a 4-day live biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia and related lymphoproliferative disorders. Dedicated to advancing state-of-the-art and emerging concepts in the pathobiology and treatment of blood cancers, iwCLL is the largest international meeting of its kind, facilitating collaboration and the exchange of information among international leaders and scientists.

Conference Directors

Jennifer Brown, MD
Dana-Farber Cancer Institute

October 7-8, 2022

LEAD: Enriching Experiences for Women in Hematology & Oncology™

One of the conferences independently organized by Bio Ascend, this program was created to empower women leaders in the hematology and oncology space. Providing essential clinical updates, career development, and professional networking, LEAD hosts national faculty during this annual event. Activities include a keynote presentation, professional vignettes, professional development workshops, and interactive panel discussions.

Conference Directors

Julie Brahmer, MD
Johns Hopkins Medicine
Nina Shah, MD

University of California San Francisco
Julie Vose, MD, MBA

University of Nebraska

Translational Workshop on Hematologic Malignancies™

This Bio Ascend summit is an invitation-only meeting for international experts who treat hematologic malignancies and individuals from sponsoring industry. A “live” virtual, 1-day program, it offers keynote presentations, expert debates, interactive panel discussions, and breakout sessions.

Conference Directors

Kieron Dunleavy, MD
George Washington Cancer Center
John Gribben, MD

Barts Cancer Institute
Sagar Lonial, MD

Emory University
Susan O’Brien, MD

University of California, Irvine

International Ultmann Chicago Lymphoma Symposium

April 29 - April 30, 2022

The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. Organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma who devoted his life to the understanding of this disease, IUCLS is a “live” virtual, multi-day program. Regional faculty participate in expert presentations, interactive case discussions, poster and abstract presentations, and Q&A sessions.

Conference Directors

Sonali Smith, MD
University of Chicago
Barbara Pro, MD
Northwestern University
Andy Evens, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey

Debates and Didactics in Hematology and Oncology

July 28-August 1, 2021 - Live and Virtual

This live/virtual hybrid, multi-day conference features a comprehensive review into mechanisms of disease and treatments for patients with cancer or a blood disorder. Expert faculty from Winship Cancer Institute of Emory University and thought leaders from across the nation will engage in interactive debates, didactic lectures, and interactive Q&A sessions on controversial topics and standards of care, offering participants the opportunity to hear how science supports each point of view.

Conference Directors

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University
Suresh Ramalingam, MD, FASCO
Winship Cancer Institute of Emory University

Updates and Impacts™

February 25, 2022 – Virtual

Updates & Impacts™: Treating Hematologic Malignancies in 2022 is a 1-day conference with the goal of disseminating recently presented data and emerging trends from the ASH Annual Meeting and Exposition led by New York-Presbyterian faculty.

Conference Directors

John Leonard, MD
Weill Cornell Medicine
Mark Heaney, MD, PhD
Columbia University Irving Medical Center

Beyond the Congress™: Key Conversations From the 2021 Hematology Annual Meeting and Exposition™

February 4, 2022 - Virtual

Beyond the Congress™: Key Conversations From the 2021 Hematology Meeting is a 1-day national conference with the goal of disseminating recently presented data and emerging trends from the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition.

Presentations from key thought leaders will focus on how scientific advances will impact clinical practice in treating lymphoma, multiple myeloma, acute and chronic leukemias, and myeloproliferative neoplasms. Join us for this complimentary educational experience!

Conference Director

John Leonard, MD
Weill Cornell Medicine

Bio Ascend converts established in-person events into virtual powerhouse experiences.

Bio Ascend was creating dynamic virtual events even before today’s conference experience pivoted almost completely from in-person events to virtual engagements. By creating and developing interactive educational offerings, a virtual experience created by Bio Ascend still accomplishes the goal of disseminating recent data and emerging trends. By pairing “live” programs chaired by today’s leading experts with prerecorded clinical presentations, interactive case discussions and expert panel discussions, we continue to attract and engage with a global audience of oncology and hematology healthcare providers.

This website uses cookies to ensure you get the best experience on our website.